Largest genetic analysis of borderline personality disorder identifies 11 risk regions and nine genes - Medical Xpress

What the report says

Medical Xpress reported on July 20, 2026, that an international research group led by the Central Institute of Mental Health in Mannheim, Germany, has completed what it described as the largest genome-wide association study yet of borderline personality disorder. The analysis, published in Nature Genetics, drew on genetic data from roughly 13,000 people diagnosed with the disorder and more than 1.1 million control participants across 14 countries.

According to the report, the study found 11 independent genomic regions associated with higher risk and identified nine candidate genes that may be involved in the disorder’s development. Researchers estimated that the genetic factors studied accounted for 17.3% of susceptibility, while a polygenic score derived from the findings predicted individual risk at 4.6% on the same scale.

The article said the findings also point to shared genetic risk between borderline personality disorder and several psychiatric and physical conditions, including post-traumatic stress disorder, depression, ADHD, antisocial behavior, suicidal and self-injurious behavior, chronic obstructive pulmonary disease and diabetes. The researchers framed this as evidence that the disorder has a complex, polygenic basis rather than a single genetic cause.

Medical Xpress noted that borderline personality disorder is marked by emotional instability, impulsivity, disturbed self-image and difficulties in relationships, and often begins in adolescence. The researchers said larger and more diverse datasets, along with deeper clinical and environmental information such as trauma exposure, will be important for clarifying mechanisms and potentially improving future care.